2m 2m 2m 2m 2m 2m 2m
VYOME HLDGS (HIND)
NASDAQ
$2.07+$0.005 (+0.24%)
Price as of Sep 11, 2026 4:29 PM EDT- $14.5MMarket Cap
- -71.78%1-Year Change
- BiotechnologyIndustry
VYOME HLDGS (HIND)
$2.07+$0.005 (+0.24%)
HIND | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.06 | ||
Change | -$0.04 (-1.90%) | ||
Open | $2.11 | ||
High | $2.11 | ||
Low | $2.05 | ||
Previous Close | $2.10 | ||
Volume | 17,529 | ||
30-Day Average Volume | 8,324 | ||
1-Week Change | -7.21% | ||
1-Month Change | -8.44% | ||
1-Year Change | -71.78% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 7.0M | ||
Total Assets | $9.2M | ||
Market Cap | $14.5M | ||
Enterprise Value | $17.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$685,556.00 | ||
Free Cash Flow | -$903,712.00 | ||
EBIT | -$685,556.00 | ||
EBITDA | -$682,946.00 | ||
Net Working Capital | $6.3M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -11 | ||
P/E | -21 | ||
PEG | -1 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 08/15/2025 | ||
Earnings & Revenue